Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

07/05/2014 The new Hewlett-Packard world development center for 3D printers will be in Barcelona 28/04/2014 Loss of memory reversed in Alzheimer's mice models 25/04/2014 More than 30 companies attended the ALBA industry workshop 15/04/2014 European Commission names Barcelona first European Capital of Innovation 11/04/2014 Visit of the Spanish State Secretary for research to the Barcelona Synchrotron Park (BSP) 02/04/2014 High-precision molding in the PTV
41 42 43 44 45 46 47 48 49